Susquehanna International Group
DNA icon

Susquehanna International Group’s Ginkgo Bioworks DNA Stock Holding History

Susquehanna International Group’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$984K Buy
160,600
+64,500
+67% +$537K ﹤0.01% 7926
2025
Q4 		$799K Sell
96,100
-189,300
-66% -$2.04M ﹤0.01% 7685
2025
Q3 		$4.16M Buy
285,400
+36,600
+15% +$438K ﹤0.01% 4391
2025
Q2 		$2.8M Sell
248,800
-98,600
-28% -$764K ﹤0.01% 5097
2025
Q1 		$1.98M Sell
347,400
-1,300
-0.4% -$13.2K ﹤0.01% 5567
2024
Q4 		$3.42M Sell
348,700
-98,500
-22% -$844K ﹤0.01% 4210
2024
Q3 		$3.64M Buy
447,200
+415,125
+1,294% +$4.16M ﹤0.01% 4174
2024
Q2 		$423K Sell
32,075
-8,363
-21% -$250K ﹤0.01% 8682
2024
Q1 		$1.88M Sell
40,438
-7,740
-16% -$401K ﹤0.01% 5491
2023
Q4 		$3.26M Sell
48,178
-5,105
-10% -$313K ﹤0.01% 4434
2023
Q3 		$3.86M Buy
53,283
+2,993
+6% +$239K ﹤0.01% 3966
2023
Q2 		$3.74M Buy
50,290
+45
+0.1% +$2.66K ﹤0.01% 4006
2023
Q1 		$2.67M Buy
50,245
+5,080
+11% +$322K ﹤0.01% 4555
2022
Q4 		$3.05M Sell
45,165
-12,965
-22% -$1.19M ﹤0.01% 3990
2022
Q3 		$7.25M Buy
58,130
+33,050
+132% +$3.94M ﹤0.01% 2599
2022
Q2 		$2.39M Sell
25,080
-8,208
-25% -$1M ﹤0.01% 4534
2022
Q1 		$5.37M Buy
33,288
+9,705
+41% +$1.89M ﹤0.01% 3519
2021
Q4 		$7.84M Buy
23,583
+12,350
+110% +$5.87M ﹤0.01% 3052
2021
Q3 		$5.21M Buy
+11,233
New +$5.47M ﹤0.01% 3875

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group's DNA Position: Q1 2026 in Review

Susquehanna International Group reduced its Ginkgo Bioworks (DNA) stake by 44% in Q1 2026, selling an estimated $372K and leaving 56,236 shares worth $345K. The position accounts for ﹤0.01% of the portfolio, ranked #10576.

Susquehanna International Group first reported a position in DNA in Q3 2021 and has held it in 19 quarters since. The position peaked at $12.8M in Q1 2022. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Susquehanna International Group held 56,236 shares of Ginkgo Bioworks worth $345K as of Q1 2026.
  • Susquehanna International Group sold 44,760 Ginkgo Bioworks shares in Q1 2026, an estimated $372K.
  • Ginkgo Bioworks made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10576 holding.
  • Susquehanna International Group first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 19 quarters since.
  • Susquehanna International Group's Ginkgo Bioworks position peaked at $12.8M in Q1 2022.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.